Rallybio, LLC
Edit

Rallybio, LLC

https://rallybio.com/
Last activity: 11.11.2022
Categories: DevelopmentBuildingLearnHumanTimeLED
Despite science’s best efforts, rare diseases remain far too common. It’s time to tackle the undone, the too difficult, and the inaccessible…
Mentions
17
Location: United States, Connecticut, New Haven
Employees: 11-50
Total raised: $182M
Founded date: 2018

Investors 8

Funding Rounds 2

DateSeriesAmountInvestors
19.05.2020Series B$145M-
26.04.2018Series A$37M-

Mentions in press and media 17

DateTitleDescriptionSource
11.11.2022Rallybio Announces Pricing of $50 Million Public OfferingRallybio Corporation ("Rallybio") RLYB today announced the pricing of an underwritten publ...einpresswi...
07.11.2022Affibody’s partner Rallybio Announces Positive Phase 1 Resul...Affibody’s partner Rallybio Announces Positive Phase 1 Results for RLYB116 Mon, Nov 07, 2022 22:08 ...news.cisio...
22.07.2021Rare disease biotech Rallybio sets terms for $81 million IPO-fprimecapi...
12.07.2021Rallybio hits high gear as it targets $100M IPO to fund trea...-solasta-ve...
19.05.2020Rallybio scores $145M, unveils lead rare disease program-fprimecapi...
19.05.2020Rallybio Scoops Up $145M Series B Round NEW HAVEN, CT, Rallybio today announced the completion of a $145 million Series B financing. >...vcnewsdail...
19.05.2020Rallybio Completes $145 Million Series BNEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio, a biopharmaceutical company committed to identifying an...citybizlis...
19.05.2020Rallybio scores $145M, unveils lead rare disease programWhen a trio of Alexion veterans started Rallybio, they vowed to take an “agnostic” approach to new m...fiercebiot...
19.05.2020Rallybio Completes $145 Million Series B Financing and Annou...-solasta-ve...
19.05.2020Rallybio Completes $145 Million Series B Financing and Annou...-5amventure...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In